Glypican-1 and Glypican-3 dysregulation is related to Notum and β-catenin alterations mostly in AOM/DSS-induced colorectal adenocarcinomas and in human colorectal tumors but also, in some cases, in early murine CRC stages. Here, GPC3 is linked to colorectal neoplasm.